| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Allogene Therapeutics, Inc. | SVP, Chief Technical Officer | Common Stock | 218K | $266K | $1.22 | Nov 17, 2025 | Direct |
| Allogene Therapeutics, Inc. | SVP, Chief Technical Officer | Stock Option (Right to buy) | 112K | Mar 1, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ALLO | Allogene Therapeutics, Inc. | Nov 17, 2025 | 1 | -$959 | 4 | Nov 19, 2025 | SVP, Chief Technical Officer |
| ALLO | Allogene Therapeutics, Inc. | Mar 14, 2025 | 1 | -$10.8K | 4 | Mar 18, 2025 | SVP, Chief Technical Officer |
| ALLO | Allogene Therapeutics, Inc. | Mar 1, 2025 | 2 | $0 | 4 | Mar 5, 2025 | SVP, Chief Technical Officer |
| ALLO | Allogene Therapeutics, Inc. | Mar 1, 2025 | 0 | $0 | 3 | Mar 4, 2025 | SVP, Chief Technical Officer |